Cancer Immunotherapy Market Research Report Information By Type of Therapy (Monoclonal Antibodies, Adoptive Cell Transfer and others), By Application (Lung Cancer, Childhood Cancer and other), By End User (Hospitals, Clinics & others) - Global Forecast till 2032

Table of Content

1. Cancer Immunotherapy Market Report Prologue

2. Cancer Immunotherapy Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Cancer Immunotherapy Market Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Cancer Immunotherapy Market Size Estimation

4. Cancer Immunotherapy Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Cancer Immunotherapy Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Cancer Immunotherapy Market, By Therapy Type

6.1 Introduction

6.2 Monoclonal Antibodies

6.2.1 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

6.3 Adoptive cell transfer

6.3.1 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

6.4 Cytokines

6.4.1 Interferon (INFs)

6.4.2 Interleukins (ILs)

6.4.3 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

6.5 Treatment Vaccines

6.5.1 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

6.6 Bacillus Calmette-Guérin

6.6.1 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

6.7 Others

7. Global Cancer Immunotherapy Market, By Application

7.1 Introduction

7.2 Liver cancer

7.2.1 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

7.3 Childhood cancer

7.3.1 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

7.4 Colorectal cancer

7.4.1 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

7.5 Stomach cancer

7.5.1 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

7.6 Lung cancer

7.6.1 Cancer Immunotherapy Market Estimates & Forecast, 2020-2027

7.7 Others

8. Global Cancer Immunotherapy Market, by End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Clinics

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Others

9. Global Cancer Immunotherapy Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Cancer Immunotherapy Market Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 F. Hoffmann-La Roche AG

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Merck & Co., Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Novartis International AG

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 GlaxoSmithKline Plc

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Amgen Inc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Bristol-Myers Squibb

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 ELI Lilly and Company

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Celgene Corporation

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Seattle Genetics, Inc.

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Spectrum Pharmaceuticals, Inc.

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.10 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical Industry

13 Appendix

LIST OF TABLES

Table 1 Cancer Immunotherapy Market Synopsis, 2020-2027

Table 2 Global Cancer Immunotherapy Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Cancer Immunotherapy Market by Region, 2020-2027, (USD Million)

Table 4 Global Cancer Immunotherapy Market by Therapy Therapy Types, 2020-2027, (USD Million)

Table 5 Global Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 6 Global Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

Table 7 North America Cancer Immunotherapy Market by Therapy Therapy Types, 2020-2027, (USD Million)

Table 8 North America Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 9 North America Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

Table 10 U.S. Cancer Immunotherapy Market by Therapy Therapy Types, 2020-2027, (USD Million)

Table 10 U.S. Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 12 U.S. Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

Table 13 Canada Cancer Immunotherapy Market by Therapy Therapy Types, 2020-2027, (USD Million)

Table 14 Canada Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 15 Canada Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

Table 16 South America Cancer Immunotherapy Market by Therapy Types, 2020-2027, (USD Million)

Table 17 South America Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 18 South America Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

Table 19 Europe Cancer Immunotherapy Market by Therapy Types, 2020-2027, (USD Million)

Table 20 Europe Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 21 Europe Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

Table 22 Western Europe Cancer Immunotherapy Market by Therapy Types, 2020-2027, (USD Million)

Table 23 Western Europe Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 24 Western Europe Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

Table 25 Eastern Europe Cancer Immunotherapy Market by Therapy Types, 2020-2027, (USD Million)

Table 26 Eastern Europe Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 27 Eastern Europe Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

Table 28 Asia Pacific Cancer Immunotherapy Market by Therapy Types, 2020-2027, (USD Million)

Table 29 Asia Pacific Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 30 Asia Pacific Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

Table 31 Middle East & Africa Cancer Immunotherapy Market by Therapy Types, 2020-2027, (USD Million)

Table 32 Middle East & Africa Cancer Immunotherapy Market by Application, 2020-2027, (USD Million)

Table 33 Middle East & Africa Cancer Immunotherapy Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Cancer Immunotherapy Market Research Process

Figure 2 Segmentation for Global Cancer Immunotherapy Market

Figure 3 Segmentation Market Dynamics for Cancer Immunotherapy Market

Figure 4 Global Cancer Immunotherapy Market Share, by Type 2020

Figure 5 Global Cancer Immunotherapy Market Share, by Application 2020

Figure 6 Global Cancer Immunotherapy Market Share, by End Users, 2020

Figure 7 Global Cancer Immunotherapy Market Share, by Region, 2020

Figure 8 North America Cancer Immunotherapy Market Share, by Country, 2020

Figure 9 Europe Cancer Immunotherapy Market Share, by Country, 2020

Figure 10 Asia Pacific Cancer Immunotherapy Market Share, by Country, 2020

Figure 10 Middle East & Africa Cancer Immunotherapy Market Share, by Country, 2020

Figure 12 Global Cancer Immunotherapy Market: Company Share Analysis, 2020 (%)

Figure 13 F. Hoffmann-La Roche AG: Key Financials

Figure 14 F. Hoffmann-La Roche AG: Segmental Revenue

Figure 16 F. Hoffmann-La Roche AG: Geographical Revenue

Figure 17 Merck & Co., Inc.: Key Financials

Figure 18 Merck & Co., Inc.: Segmental Revenue

Figure 19 Merck & Co., Inc.: Geographical Revenue

Figure 20 Novartis International AG: Key Financials

Figure 21 Novartis International AG: Segmental Revenue

Figure 22 Novartis International AG: Geographical Revenue

Figure 23 GlaxoSmithKline Plc: Key Financials

Figure 24 GlaxoSmithKline Plc: Segmental Revenue

Figure 25 GlaxoSmithKline Plc: Geographical Revenue

Figure 26 Amgen Inc.: Key Financials

Figure 27 Amgen Inc.: Segmental Revenue

Figure 28 Amgen Inc.: Geographical Revenue

Figure 29 Bristol-Myers Squibb: Key Financials

Figure 30 Bristol-Myers Squibb: Segmental Revenue

Figure 31 Bristol-Myers Squibb: Geographical Revenue

Figure 32 ELI Lilly and Company: Key Financials

Figure 33 ELI Lilly and Company: Segmental Revenue

Figure 34 ELI Lilly and Company: Geographical Revenue

Figure 35 Celgene Corporation: Key Financials

Figure 36 Celgene Corporation: Segmental Revenue

Figure 37 Celgene Corporation: Geographical Revenue

Figure 38 Seattle Genetics, Inc.: Key Financials

Figure 39 Seattle Genetics, Inc.: Segmental Revenue

Figure 40 Seattle Genetics, Inc.: Geographical Revenue

Figure 41 Spectrum Pharmaceuticals, Inc.: Key Financials

Figure 42 Spectrum Pharmaceuticals, Inc.: Segmental Revenue

Figure 43 Spectrum Pharmaceuticals, Inc.: Geographical Revenue